Table 3. Gene expressions in Bmal1 -/- mice.

	Liver		Muscle
	ZT10	ZT22	ZT10	ZT22
Fatty acid binding and transpot
Cd36	2.7±0.3*	1.1±0.1	1.2±0.2	1.4±0.2
Fabp5	4.3±0.4*	1.5±0.1*	1.1±0.1	0.9±0.2
Ldlr	0.8±0.3	1.0±0.2	0.2±0.1*	0.2±0.2*
Lpl	77.9±8.5*	79.3±9.1*	1.1±0.2	0.9±0.1
Srbi	2.7±0.3*	1.5±0.1*	0.7±0.3	1.1±0.2
TG and fatty acid synthesis
Agat2	0.8±0.8	0.6±0.3	1.1±0.1	1.3±0.2
Agat3	1.0±0.2	1.1±0.1	2.0±0.2*	1.8±0.2*
Dgat1	0.6±0.2*	0.7±0.1	0.9±0.2	1.1±0.1
Dgat2	0.5±0.1*	0.5±0.1*	0.6±0.2*	0.4±0.2*
Fasn	0.3±0.0*	0.3±0.0*	6.3±0.6*	1.1±0.2
Scd1	1.3±0.2	0.3±0.1*	5.0±1.1*	2.0±0.3*
Fatty acid oxidation
Acaa 1a	0.6±0.1*	0.5±0.1*	0.8±0.2	0.7±0.2
Acaa 1b	0.3±0.1*	0.2±0.0*	0.6±0.3	0.6±0.3
Acadl	1.7±0.2	0.7±0.2	1.6±0.2*	0.9±0.2
Acadm	0.7±0.3	0.7±0.2	1.7±0.3*	1.3±0.1
Echdc1	0.6±0.1*	0.5±0.1*	1.3±0.3	0.9±0.1

Gene expressions in control mice and Bmal1 -/- mice were determined by RT-qPCR. Relative mRNA levels were normalized to the 36B4 level. Each value represented the mean fold-changes (± SEM) of Bmal1 -/- mice in comparison to control mice (n = 5 for each genotype and point). Asterisks indicate significant differences (P<0.05).